| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Ansuvimab Basic information |
| Product Name: | Ansuvimab | | Synonyms: | Ansuvimab;Research Grade Ansuvimab (DVV03607);Research Grade Ansuvimab | | CAS: | 2375952-29-5 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Ansuvimab Structure]() |
| | Ansuvimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Ansuvimab Usage And Synthesis |
| Uses | Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells[1]. | | in vivo | Ansuvimab results in all macaques surviving after exposure to a lethal dose of Ebola virus in on day 0[1]. | | IC 50 | ZEBOV | | References | [1] Lee A, et, al. Ansuvimab: First Approval. Drugs. 2021 Apr;81(5):595-598. DOI:10.1007/s40265-021-01483-4
[2] Corti D, et, al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016 Mar 18;351(6279):1339-42. DOI:10.1126/science.aad5224 |
| | Ansuvimab Preparation Products And Raw materials |
|